Implementation of these tests for screening of blood donors will reduce the risk of HCV after transfusion still further (down to approximately one in 300,000 in the US, for example). A test ...

Background: Transfusion-dependent bone marrow transplant recipients are routinely transfused with ABO group and RhD-compatible blood components. However, because of the scarcity of RhD-negative ...